The comparability of different neuron-specific enolase
immunoassays and its impact on external quality
assessment system
Štern P.1, 2, Bartoš V.3, Uhrová J.1, Springer D.1, Vaníčková Z.1, Tichý V.4, Průša R.5, Zima T.1
1Institute of Clinical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University, Prague 2Department of Clinical Biochemistry, Institute for Postgraduate Medical Education, Prague 3Department of Nuclear Medicine, University Hospital and Policlinic, Ostrava 4Department of Clinical Biochemistry and Haematology, Centromed, Prague 5Institute of Clinical Chemistry and Pathobiochemistry, Faculty Hospital Motol, Prague |
|
Fulltext
Summary:
Objective: Long-term external quality assessments suggest that the individual results of different immunoassays are
often not comparable. Our goal was to assess the possible sources of these differences.
Methods: The paper is based on the results of analyses using seven different immunoassays: DELFIA (PerkinElmer),
Elecsys 2010 (Roche), Kryptor (B.R.A.H.M.S.), the enzyme-linked immunosorbent assay DRG and three methods
based on immunoradiometric assays (DiaSorin, Immunotech and Schering-CIS).
Results: The following parameters were evaluated: precision profile of individual methods, linearity on dilution, modified
recovery and comparability of immunoassays.
The analytical results for certain low concentration specimens correlate well while others do not (up to five – fold
difference), especially in the case of controls prepared synthetically. Therefore, the current non-standardized preparation
of controls seems to be questionable. In the cut-off range, the difference in the results of native samples does not
exceed its double value. The variation in values higher than 100 µg/l obtained with different assays is under 40 %. All
the evaluated immunoassays are efficient and highly comparable (The correlation coefficients are up to 0.994).
Conclusion: Our results confirm the expected matrix interference occurring especially in the range of normal and cut-off
NSE concentrations. Another source of discrepancies can be put down to different antibody affinity to αγ- and
γγ-enolase isoenzymes.
Key words:
neuron-specific enolase, NSE, precision, recovery, comparability, EQA.
|